Sevoflurane Ameliorates Schizophrenia in a Mouse Model and Patients: A Pre-Clinical and Clinical Feasibility Study

BACKGROUND: GABAergic deficits have been considered to be associated with the pathophysiology of schizophrenia, and hence, GABA receptors subtype A (GABA(A)Rs) modulators, such as commonly used volatile anesthetic sevoflurane, may have therapeutic values for schizophrenia. The present study investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tianyun, Shi, Ziwen, Ling, Nongxi, Qin, Jingwen, Zhou, Quancai, Wu, Lingzhi, Wang, Yuansheng, Lin, Chuansong, Ma, Daqing, Song, Xingrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890293/
https://www.ncbi.nlm.nih.gov/pubmed/35272593
http://dx.doi.org/10.2174/1570159X20666220310115846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890293/
https://www.ncbi.nlm.nih.gov/pubmed/35272593
http://dx.doi.org/10.2174/1570159X20666220310115846

Ejemplares similares